Charlie Latham

Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia.

Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen.

Austofix Group Ltd. designs manufactures and sales orthopedic trauma devices. It operates through two segments manufacturing of implants and distribution. The manufacturing of implants segment manufactures metal plates, screws and nails for implanting into patients, instruments for the use of surgeons and components for other manufacturers. The distribution segment distributes austofix products around Australia and internationally. The company was founded by Anthony Mark Ingman in 1993 and is headquartered in Adelaide, Australia.